Introduction {#Sec1}
============

Growth and obesity are complex phenotypic traits with a moderate to strong genetic basis in mammals (Bouchard [@CR6]; Mignon-Grasteau et al. [@CR35]), and both traits are linked to health disorders in humans and domestic animals (Bouchard [@CR6]; Brindley and Rolland [@CR8]; Lew and Garfinkel [@CR32]). Mouse models have provided valuable insight into the genetic architecture of growth and obesity through the identification of single-gene mutations (de Magalhães et al. [@CR15]; Horvat and Medrano [@CR26]; Zhang et al. [@CR52]), quantitative trait loci (QTL) (Corva and Medrano [@CR14]; Farber and Medrano [@CR18]; Warden et al. [@CR47]), epistatic interactions between different genomic regions (Brockmann et al. [@CR9]), and quantification of the additive genetic variance (Maes et al. [@CR34]).

Genetic analyses of growth and obesity traits in mice have typically focused on direct genetic effects without taking into account the effects of the maternal genotype. Some studies support the importance of maternal genetic contributions (Jarvis et al. [@CR28]; Wolf et al. [@CR49]), but they only broadly characterized the effects and have not localized associated genomic regions (Jarvis et al. [@CR28]). Recent studies focusing on the identification of QTL for growth and obesity have suggested the presence of maternal effects on chromosomes 2 and 7 in two sets of subcongenic strains (Diament and Warden [@CR16]; Farber and Medrano [@CR18]). In the present study we further investigate each subcongenic set using a QTL fine-mapping approach focused on the overlapping donor regions to identify maternal QTL affecting the phenotypes in adulthood.

The analysis of maternal effects that influence traits in adults has become a major field of research in recent years, characterizing a biological phenomenon known as fetal programming (Schwartz and Morrison [@CR43]). The fetal programming hypothesis proposes that alterations in fetal or early neonatal nutrition and endocrine status result in developmental adaptations that permanently change structure, physiology, and metabolism (Barker [@CR2]), influencing both adult health (Godfrey and Barker [@CR22]) and phenotypic performance (Wu et al. [@CR50]). Fetal programming has been associated with atherosclerosis (Goharkhay et al. [@CR23]), obesity (Yura et al. [@CR51]), cardiovascular disease (Remacle et al. [@CR42]), and fertility (Abbott et al. [@CR1]) in mouse, although little is known about the genetic architecture of these maternal influences. The analysis of the putative genetic mechanisms regulating fetal programming in mice could contribute useful information to the understanding of the genetic basis of growth and obesity in mammals.

Materials and methods {#Sec2}
=====================

Mouse husbandry {#Sec3}
---------------

Two independent sets of subcongenic mouse strains with donor regions on chromosomes 2 and 7 (Figs. [1](#Fig1){ref-type="fig"} and [2](#Fig2){ref-type="fig"}) were developed as described by Farber and Medrano ([@CR18]) and Warden et al. ([@CR47]), and maintained in different vivariums at the University of California-Davis. Note that these were independent mouse populations developed and maintained under different management conditions (e.g., facility, diet; see below). Mice were housed in groups of two to five in polycarbonate cages bedded with a 2:1 mixture of CareFRESH (Absorption Corp., Ferndale, WA) and soft paper chips (Canbrands Intl., Moncton, Canada) and maintained under controlled conditions of temperature (21 ± 2°C), humidity (40--70%), and lighting (14 h light, 10 h dark, lights on at 7 a.m.). Mice were weaned at 3 weeks of age. Chromosome 2 subcongenic strains (and founder stains) were fed with Purina Laboratory Rodent Diet 5008 (Labdiet^®^, Purina Mills, Inc., St. Louis, MO; 23.5% protein, 6.5% fat, 3.3 kcal/g), whereas chromosome 7 subcongenic mice were fed Research Diets AIN-76A (Research Diets, Inc., New Brunswick, NJ; 20.8% protein from casein, 67.7% carobydrate from sucrose, 11.5% fat from corn oil, 3.9 kcal/g). Food and water were offered ad libitum. All mouse protocols were managed according to the guidelines of the American Association for Accreditation of Laboratory Animal Care (AAALAC; <http://www.aaalac.org>).Fig. 1Summary of the maternal QTL in mouse chromosome 2. *Bottom* Locations of the subcongenic strains and boundary markers (red areas represent CAST/EiJ alleles and gray areas represent C57BL6/J alleles; alleles residing between adjacent markers typed as CAST/EiJ and C57BL6/J are undetermined and highlighted in blue; only boundary markers are included). *TopP*-value plots for maternal QTL affecting body weight (2WK, 3WK, 6WK, and 9WK, i.e., body weight at 2, 3, 6, and 9 weeks of age, respectively), organ (*LW* liver weight, *SW* spleen weight, *KW* kidneys weight, *HW* heart weight, *TW* testis weight), and fat pads weight (*GFP* gonadal fat pads, *RFP* retroperitoneal fat pad, *MFP* mesenteric fat pad, *FFP* femoral fat pads, *TFP* total fat pads weight). The dotted horizontal line represents the significance threshold under Bonferroni's correction (α = 0.05; *P* = 1.62 × 10^-4^)Fig. 2Summary of the maternal QTL in mouse chromosome 7. *Bottom* Locations of the subcongenic strains and boundary markers (red areas represent B6.C-Tyr^c^H1^b^Hbb^d^/By alleles and gray areas represent C57BL/6ByJ alleles; alleles residing between adjacent markers typed as B6.C-Tyr^c^H1^b^Hbb^d^/By and C57BL/6ByJ are undetermined and highlighted in blue; only boundary markers are included). *TopP*-value plots for maternal QTL affecting body size (*BL* body length, *BW* body weight, *CW* carcass weight) and fat pads weight (*GFP* gonadal fat pads, *RFP* retroperitoneal fat pad, *MFP* mesenteric fat pad, *FFP* femoral fat pads, *TFP* total fat pads weight). The spotted horizontal line highlights the significance threshold under Bonferroni's correction (α = 0.05; *P* = 4.46 × 10^-4^)

Genotyping {#Sec4}
==========

During the development of chromosome 2 subcongenic strains, mice were genotyped for 36 microsatellite loci (*D2Mit329*, *D2Mit93*, *D2Mit94*, *D2Mit160*, *D2Mit476*, *D2Mit15*, *D2Mit439*, *D2Mit130*, *D2Mit389*, *D2Mit43*, *D2Mit477*, *D2Mit185*, *D2Mit58*, *D2Mit207*, *D2Mit101*, *D2Mit420*, *D2Mit445*, *D2Mit17*, *D2Mit224*, *D2Mit107*, *D2Mit488*, *D2Mit223*, *D2Mit136*, *D2Mit490*, *D2Mit212*, *D2Mit194*, *D2Ucd22*, *D2Mit260*, *D2Mit286*, *D2Mit409*, *D2Mit262*, *D2Mit196*, *D2Mit342*, *D2Mit456*, *D2Mit213*, and *D2Mit148*; Table [1](#Tab1){ref-type="table"}) and the nonagouti locus. DNA samples were isolated from 1.0-mm tail clips and genotyped following standard PCR protocols as described by Farber et al. ([@CR19]). Chromosome 7 subcongenic strains were genotyped by standard PCR protocols for ten microsatellite loci (*D7Mit318*, *D7Mit90*, *D7Mit62*, *D7Mit301*, *D7Mit373*, *D7Mit321*, *D7Mit354*, *D7Mit353*, *D7Mit96*, and *D7Mit37*; Table [1](#Tab1){ref-type="table"}) after extracting DNA samples from kidney or toe (Diament and Warden [@CR16]). Marker *D7Mit37* is placed as the most distal marker by the Ensembl genome browser (Ensembl; <http://www.ensembl.org>) and by the National Center for Biotechnology Information (NCBI; <http://www.ncbi.nlm.nih.gov>), whereas Celera (http:[www.celera.com](http://www.celera.com)) assumes two copies, one placed in the distal location and the other one placed between markers *D7Mit373* and *D7Mit321*. Our analyses were performed on the basis of *D7Mit37* placed at the most distal position.Table 1Microsatellite markers typed in the chromosome 2 and chromosome 7 subcongenic strainsMarkerMb^a^MarkerMb^a^Chromosome 2*D2Mit212*141.8*D2Mit329*74.9*D2Mit194*143.8*D2Mit93*76.7*D2Ucd22*146.0*D2Mit94*80.0*D2Mit260*149.0^b^*D2Mit160*84.8*D2Mit286*154.3*D2Mit476*86.3Nonagouti154.8*D2Mit15*91.9*D2Mit409*158.3*D2Mit439*92.0*D2Mit262*155.7*D2Mit130*97.4*D2Mit196*160.3*D2Mit389*103.1*D2Mit342*164.7*D2Mit43*104.0*D2Mit456*168.8*D2Mit477*104.4*D2Mit213*174.4*D2Mit185*105.3*D2Mit148*178.5*D2Mit58*108.1*D2Mit207*112.0Chromosome 7*D2Mit101*114.9*D7Mit318*81.1*D2Mit420*118.1^b^*D7Mit90*87.5*D2Mit445*121.1*D7Mit62*91.8*D2Mit17*122.6^b^*D7Mit301*98.7*D2Mit224*129.1*D7Mit373*103.2*D2Mit107*133.1*D7Mit321*105.1*D2Mit488*133.1*D7Mit354*106.1*D2Mit223*134.7^b^*D7Mit353*106.7*D2Mit136*136.2*D7Mit96*107.7*D2Mit490*138.7*D7Mit37*111.0^a^Mb according to Ensembl genome browser (<http://www.ensembl.org>) April 2007 assembly (Hubbard et al. [@CR27])^b^Mb according to UCSC Genome Bioinformatics (<http://genome.ucsc.edu>) July 2007 assembly (Karolchik et al. [@CR31])

Subcongenic F~2~ crosses {#Sec5}
------------------------

For mouse chromosome 2, seven subcongenic strains were developed from the B6.CAST-(*D2Mit329-D2Mit457*)N(6) congenic strain (B62D) (Farber and Medrano [@CR18]; Farber et al. [@CR19]). Five additional subcongenic strains were generated on the basis of the HG.CAST-(*D2Mit329-D2Mit457*)N(6) congenic line (HG2D) (R. J. Gularte, personal communication), following the procedures detailed by Farber and Medrano ([@CR18]). Both B62D and HG2D possessed identical CAST/EiJ donor regions introgressed on C57BL6/J (B6) and C57BL/6 J-*hg*/*hg* (HG) (Corva and Medrano [@CR13]) backgrounds, respectively. Note that the HG strain is isogenic to B6, except for the high growth locus, a 500-kb deletion on mouse chromosome 10 (Horvat and Medrano [@CR26]). As described by Farber and Medrano ([@CR18]), seven B6 × (B62D × B6) males with narrow (approximately 20 Mb) overlapping donor regions were selected and backcrossed to B6 females to generate large numbers of F~1~ heterozygous mice of both sexes. Subcongenic F~2~ populations were created by intermating F~1~ heterozygous mice derived from each of the seven founders. In a similar way, the F~2~ HG2D subcongenic populations were generated from five HG × (HG2D × HG) males with narrow overlapping donor regions mated with HG females and the subsequent mating of heterozygous F~1~ individuals (R. J. Gularte, personal communication). See Table [2](#Tab2){ref-type="table"} and Fig. [1](#Fig1){ref-type="fig"} for a detailed characterization of F~2~ populations and donor regions.Table 2Summary of the subcongenic F~2~ crosses and their congenic regions*N*MalesFemalesLittersBoundary microsatellites of the congenic regionChromosome 2 subcongenicsB62D-18787015*D2Mit329D2Mit476*B62D-2128128019*D2Mit94D2Mit101*HG2D-136315920452*D2Mit43D2Mit103*B62D-3157157025*D2Mit477D2Mit103*B62D-4145145024*D2Mit207D2Mit17*HG2D-22339513827*D2Mit420D2Mit490*B62D-5111111021*D2Mit445D2Mit107*B62D-6118118017*D2Mit107D2Mit194*B62D-7129129022*D2Mit490D2Mit409*HG2D-337118918247*D2Mit194D2Mit262*HG2D-433616617038*D2Mit286D2Mit213*HG2D-537717020750*D2Mit456D2Mit148*Overall25551654901357Chromosome 7 subcongenicsB6.C-H15151031*D7Mit318D7Mit37*B6.C-C7676044*D7Mit318D7Mit318*B6.C-D2424014*D7Mit18D7Mit90*B6.C-M3636022*D7Mit90D7Mit90*B6.C-N8686051*D7Mit90D7Mit62*B6.C-L3333019*D7Mit62D7Mit301*B6.C-A4747031*D7Mit 301D7Mit301*B6.C-B2929020*D7Mit301D7Mit37*B6.C-I8888044*D7Mit373D7Mit373*B6.C-F123123071*D7Mit373D7Mit37*B6.C-H4848026*D7Mit37D7Mit37*B6.C-J5757036*D7Mit37D7Mit37*B6.C-K2929014*D7Mit37D7Mit37*B6.C-E2222013*D7Mit321D7Mit321*B6.C-G3131014*D7Mit354D7Mit354*Overall7807800450

Subcongenic strains for mouse chromosome 7 were developed from the BALB/cByJ (B6.C-H1) congenic strain (The Jackson Laboratory, Bar Harbor, ME, USA), a commercially available strain retaining the H1 histocompatibility antigen allele of the BALB/cBy strain on the background of the C57BL/6ByJ (B6By) strain. Fourteen subcongenic strains were generated by backcrossing B6By × B6.C-H1 mice to B6By mice. Then, each recombinant mouse containing only a part of the full congenic region was backcrossed again to B6By and genotyped to produce F~1~ progeny with identical recombinant donor region boundaries. These heterozygous progeny were sib-mated to produce F~2~ littermate mice of all three genotype classes (Diament and Warden [@CR16]). The genomic intervals captured by each subcongenic strain are summarized in Fig. [2](#Fig2){ref-type="fig"} and Table [2](#Tab2){ref-type="table"}.

Recording of phenotypic data {#Sec6}
----------------------------

Genotypes were available for mice in all generations (F~0~, F~1~, and F~2~) and phenotypic information was collected from all F~2~ mice from each subcongenic. Chromosome 2 subcongenic male and female mice were weighed at 2 (2WK), 3 (3WK), 6 (6WK), and 9 (9WK) weeks of age. At sacrifice (9WK ± 5 days), mice were weighed, anesthetized under isofluorane, sacrificed by decapitation, and exsanguinated. The weight of liver (LW), spleen (SW), kidneys (KW), heart (HW), and testis (TW) were registered. Gonadal fat pads (GFP; adipose tissue surrounding the gonads and other reproductive organs), retroperitoneal fat pad (RFP; fat deposit behind each kidney along the lumbar muscles), mesenteric fat pad (MFP; adipose tissue surrounding the gastrointestinal tract from the gastroesophageal sphincter to the end of the rectum), and femoral fat pads (FFP; subcutaneous adipose deposit from the outer thigh) were dissected following Johnson and Hirsch ([@CR29]). Total fat pad weight (TFP) was calculated as the sum of GFP, RFP, MFP, and FFP. At 16--18 weeks of age, chromosome 7 subcongenic male mice were anesthetized with isofluorane and measurements of body length (BL) and weight (BW) were taken. Animals were sacrificed by cervical dislocation. After sacrifice, carcass weight (CW) was registered and gonadal, retroperitoneal, mesenteric, and femoral fat pads were dissected and weighed as described by Warden et al. ([@CR47]). See Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"} for a detailed summary of available mice and phenotypic records.Table 3Number of phenotypic records and summary statistics for the analyzed traitsTrait*n*Mean ± SEChromosome 2 subcongenicsWeight at 2 weeks of age (g)25417.467 ± 0.025Weight at 3 weeks of age (g)255310.688 ± 0.035Weight at 6 weeks of age (g)254425.741 ± 0.085Weight at 9 weeks of age (g)254830.200 ± 0.111Liver weight (g)25311.339 ± 0.005Spleen weight (g)25270.098 ± 0.001Kidneys weight (g)25320.316 ± 0.001Heart weight (g)25260.149 ± 0.001Testis weight (g)16360.130 ± 0.002Gonadal fat pads weight (g)25270.392 ± 0.002Retroperitoneal fat pad weight (g)25270.079 ± 0.001Mesenteric fat pad weight (g)25270.230 ± 0.001Femoral fat pads weight (g)25270.345 ± 0.002Total fat pads weight (g)25251.045 ± 0.005Chromosome 7 subcongenicsBody length (cm)7759.822 ± 0.010Body weight (g)78026.593 ± 0.105Gonadal fat pads weight (g)7800.556 ± 0.011Retroperitoneal fat pad weight (g)7740.195 ± 0.005Mesenteric fat pad weight (g)7790.171 ± 0.004Femoral fat pads weight (g)7800.311 ± 0.006Total fat pads weight (g)7801.233 ± 0.024Carcass weight (g)76624.871 ± 0.102

Statistical analyses {#Sec7}
--------------------

As shown in Figs. [1](#Fig1){ref-type="fig"} and [2](#Fig2){ref-type="fig"}, the donor regions of subcongenic strains with donor regions on the same chromosome partially overlapped. This property allowed us to define 22 overlapping regions (OR) on chromosome 2 and 15 OR on chromosome 7 (see Figs. [1](#Fig1){ref-type="fig"} and [2](#Fig2){ref-type="fig"}). Note that OR were sequentially numbered from 2.1 to 2.22 in chromosome 2 (Fig. [1](#Fig1){ref-type="fig"}) and from 7.1 to 7.15 in chromosome 7 (Fig. [2](#Fig2){ref-type="fig"}). Although previous analyses performed on these data modeled maternal genetic contributions on the broad basis of each subcongenic strain (Diament and Warden [@CR16]; Farber and Medrano [@CR18]), the OR approach allowed fine-mapping (\~10 Mb) of maternal QTL by examining differences between background/background and donor/background F~1~ females (mothers of the F~2~ population) at each genomic location. As was initially applied by Clee et al. ([@CR11]) on a direct QTL, this analysis extends the method for QTL mapping by allowing for strain differences at each OR. The specific genetic architecture of our subcongenic strains was used to test differences in offspring phenotypic performance in relation to the maternal genetic background within each overlapping region. For chromosome 2, 22 analyses focused on each overlapping region were performed for 14 phenotypic traits (Fig. [1](#Fig1){ref-type="fig"}) using the following mixed model,$$\documentclass[12pt]{minimal}
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\begin{document}$$ y_{\rm ijklmno} = d_{\rm i} + {\text{OOR}}_{\rm j} + {\text{DOR}}_{\rm k} + {\text{HG}}_{\rm l} + {\text{SS}}_{\rm m} + {\text{SX}}_{\rm n} + {\text{AS}}_{\rm o} + e_{\rm ijklmno} $$\end{document}$$where *y*~ijklmno~ and *e*~ijklmno~ were the phenotypic record and residual term belonging to the *o*th mouse, respectively. This model accounts for the random environmental effect of each dam (*d*~i~), the genotype of the offspring in the overlapping chromosomal regions (background/background, background/donor, or donor/donor; OOR~j~), dam genotype in the chromosomal overlapping region (background/donor or background/background; DOR~k~), genotype for the high-growth locus (high growth or wild type; HG~l~), subcongenic strain (12 strains; SS~m~), sex (male or female; SX~n~) and age at sacrifice (AS~o~) as continuous effect. Preliminary analyses of fat pad weights also accounted for weight at sacrifice, although this factor was dropped from the operational model because it did not reach statistical significance when compared with age at sacrifice. On chromosome 2, maternal influences were captured by *d*~i~ (genetic and environmental influences related to the dam) and DOR~k~ (genetic effects restricted to the analyzed chromosomal overlapping region) effects, whereas direct genetic effects were inferred by OOR~j~ (loci located in the analyzed chromosomal overlapping region), HG~l~ (high-growth genotype), and SS~m~ (genetic background of each subcongenic strain) or accumulated in the residual term (*e*~ijklmno~). The separation of maternal and direct genetic sources of variation was accomplished by including the two factors DOR~k~ and OOR~j~ in the model; both of this factors could be partially correlated. The same operational model was used to analyze chromosome 7 subcongenic strains but without the HG~l~ term, since the high-growth mutation was not present in B6.C-H1 mice. For both chromosomes 2 and 7 subcongenic strains, an independent analysis was sequentially performed on each chromosomal overlapping region (note that overlapping regions 7.12 and 7.14 were contributed by the same subcongenic strains with donor genotype: B6.C-H1, B6.C-B, B6.C-F, B6.C-J, and B6.C-K; Fig. [2](#Fig2){ref-type="fig"}). Inference was focused on DOR~k~ in order to scan maternal QTL with effects on growth and obesity traits in mice. Although *d*~i~ could also capurate some genetic variability due to mutations (Casellas and Medrano [@CR10]) in the background genome, its main effect must be due to environmental sources of variation and without additional contributions to the maternal QTL.

When the QTL scan detected two or more significant peaks for a given trait, the appropriate DOR~k~ effects associated with the minimum *P*-value locations were jointly analyzed in the same model (with the remaining systematic and random sources of variation defined above) to determine their statistical relevance in this population of congenic mice. All analyses were performed with the Mixed procedure of SAS 8.2 (SAS Institute, Inc., Cary, NC). Given that these analyses were performed within a multiple-testing scheme, Bonferroni's correction was applied (α = 0.05). Threshold for statistical significance was placed at *P* = 1.62 × 10^-4^ (chromosome 2) and *P* = 4.46 × 10^-4^ (chromosome 7).

Results {#Sec8}
=======

Maternal QTLs for growth and organ weight in mouse chromosomes 2 and 7 {#Sec9}
----------------------------------------------------------------------

A significant QTL was detected for 9WK (*P* = 1.23 × 10^−5^; Fig. [1](#Fig1){ref-type="fig"}) within the chromosomal region flanked by markers *D2Mit477* and *D2Mit207* (OR 2.5). The remaining growth traits (2WK, 3WK, and 6WK) had similar *P*-value profiles but failed to reach statistical significance after correcting for multiple testing. The peak additive effect was negative (−0.828 ± 0.233 g), indicating that maternal CAST/EiJ alleles reduced adult weight at 9 weeks in the offspring.

All organ weights showed significant maternal QTL on mouse chromosome 2 with the exception of heart (*P* \> 0.23; Fig. [1](#Fig1){ref-type="fig"}). Two maternal QTL were detected for KW between *D2Mit329* and *D2Mit94* (*P* = 8.55 × 10^−8^; OR 2.1) and between *D2Mit107* and *D2Mit194* (*P* = 1.12 × 10^−6^; OR 2.13--2.15), with positive and negative effects for CAST/EiJ alleles on organ weight, respectively (Table [4](#Tab4){ref-type="table"}). In a similar way, two maternal QTL with opposite effects were obtained for TW between *D2Mit477* and *D2Mit101* (*P* = 6.32 × 10^−7^; OR 2.5--2.6) and between *D2Mit107* and *D2Mit194* (*P* = 6.96 × 10^−8^; OR 2.13--2.15). For both KW and TW, the two maternal QTL were corroborated under joint analyses with *P* ≤ 7.21 × 10^−5^ for all cases. The two remaining organs (LW and SW) showed a unique maternal QTL between markers *D2Mit477* and *D2Mit101* (*P* = 3.50 × 10^−7^ and *P* = 1.46 × 10^−7^, respectively; OR 2.5 and 2.6), although slightly differing in the location of the *P*-value peak (between *D2Mit477* and *D2Mit207* for LW and between *D2Mit207* and *D2Mit101* for SW; Table [4](#Tab4){ref-type="table"}).Table 4Maternal QTL in mouse chromosomes 2 and 7 (single-QTL analysis)Trait^a^Boundary microsatellites*P* value^b^QTL effect^b,c^Phenotypic variance^d^ (%)Chromosome 29WK (g)*D2Mit185* to *D2Mit207*1.23 × 10^−5^−0.828 ± 0.2331.9LW (g)*D2Mit185* to *D2Mit101*3.50 × 10^−7^−0.065 ± 0.0122.5SW (g)*D2Mit185* to *D2Mit101*1.46 × 10^−7^−0.006 ± 0.0011.3KW (g)*D2Mit329* to *D2Mit94*8.55 × 10^−8^0.036 ± 0.00611.7KW (g)*D2Mit107* to *D2Mit194*1.12 × 10^−6^−0.022 ± 0.0049.7TW (g)*D2Mit185* to *D2Mit101*6.32 × 10^−7^0.010 ± 0.0015.4TW (g)*D2Mit107* to *D2Mit194*6.96 × 10^−8^−0.020 ± 0.0033.1GFP (g)*D2Mit185* to *D2Mit101*1.62 × 10^−5^0.038 ± 0.0087.2RFP (g)*D2Mit185* to *D2Mit101*2.81 × 10^−5^0.011 ± 0.0022.1FFP (g)*D2Mit185* to *D2Mit101*5.81 × 10^−7^0.027 ± 0.0053.7TFP (g)*D2Mit185* to *D2Mit101*6.83 × 10^−6^0.087 ± 0.0197.2Chromosome 7BL (cm)*D7Mit62* to *D7Mit301*1.34 × 10^−5^−0.126 ± 0.0393.3BW (g)*D7Mit90* to *D7Mit373*1.90 × 10^−8^−2.176 ± 0.4848.9CW (g)*D7Mit373* to *D7Mit321*2.32 × 10^−5^−1.083 ± 0.3542.4GFP (g)*D7Mit90* to *D7Mit62*1.44 × 10^−7^−0.171 ± 0.0427.6GFP (g)*D7Mit301* to *D7Mit373*2.34 × 10^−9^−0.238 ± 0.0499.7RFP (g)*D7Mit90* to *D7Mit62*2.07 × 10^−7^−0.075 ± 0.0135.0RFP (g)*D7Mit301* to *D7Mit373*1.79 × 10^−7^−0.093 ± 0.0227.2MFP (g)*D7Mit90* to *D7Mit90*1.62 × 10^−5^−0.044 ± 0.0142.7MFP (g)*D7Mit301* to *D7Mit301*9.67 × 10^−5^−0.043 ± 0.0152.5FFP (g)*D7Mit90* to *D7Mit62*8.58 × 10^−7^−0.093 ± 0.0246.1FFP (g)*D7Mit301* to *D7Mit373*2.17 × 10^−6^−0.110 ± 0.0296.9TFP (g)*D7Mit90* to *D7Mit62*2.78 × 10^−7^−0.380 ± 0.0972.5TFP (g)*D7Mit301* to *D7Mit373*4.89 × 10^−8^−0.496 ± 0.1142.7^a^*9WK* Weight at 9 weeks of age, *BL* Body length, *BW* Body weight, *CW* Carcass weight, *LW* Liver weight, *SW* Spleen weight, *KW* Kidneys weight, *TW* Testes weight, *GFP* Gonadal fat pads weight, *RFW* Retroperitoneal fad pads weight, *MFW* Mesenteric fat pad weight, *FFP* Femoral fad pads weight, *TFP* Total fad pads weight^b^When a QTL spanned two or more overlapping regions, estimates were focused on the region with smaller *P* value^c^Estimates as the difference between donor and background genetic environments^d^Percentage of the phenotypic variance accounted for by the maternal QTL

On chromosome 7, BW showed a two-peak profile (Fig. [2](#Fig2){ref-type="fig"}); however, only the maternal QTL placed between markers *D7Mit301* and *D7Mit373* (OR 7.7--7.9) remained significant after the joint analysis of both QTL (*P* = 4.15 × 10^−7^). Maternal QTL for BL and CW were detected between *D7Mit62* and *D7Mit301* (*P* = 1.34 × 10^−5^; OR 7.5--7.7) and between *D7Mit373* and *D7Mit321* (*P* = 2.32 × 10^−5^; OR 7.9--7.11), respectively. All three maternal QTL implied a reduction in body weight and length linked with B6.C-H1 alleles (Table [4](#Tab4){ref-type="table"}).

The maternal QTL accounted for a significant percentage of the phenotypic variance, between 1.9% (9WK) and 11.7% (KW) for chromosome 2 QTL and between 2.4% (CW) and 8.9% (BW) for chromosome 7 QTL (Table [4](#Tab4){ref-type="table"}). These values were similar or slightly larger than those obtained by the direct effect of the offspring's genotype, OOR~j~, in the same genomic regions (between 3.4 and 7.5%).

Maternal QTL for fat pad weight on mouse chromosomes 2 and 7 {#Sec10}
------------------------------------------------------------

Chromosome 2 maternal QTL for fat pad weights had similar profiles, although MFP did not reach statistical significance (Fig. [1](#Fig1){ref-type="fig"}). A hotspot for genetic maternal contribution to offspring obesity was detected between markers *D2Mit477* and *D2Mit101* (OR 2.5 and 2.6), although maximum peaks were placed between *D2Mit207* and *D2Mit101* (*P* ≤ 2.81 × 10^−5^; OR 2.6). The effect was favorable to CAST/EiJ alleles promoting obesity in all cases, with increases in fat pad weight ranging between 0.011 ± 0.002 g (RFP) and 0.087 ± 0.019 (TFP; Table [4](#Tab4){ref-type="table"}). These maternal QTL accounted for 2.1% (RFP) to 7.2% (GFP and TFP) of the phenotypic variance (Table [4](#Tab4){ref-type="table"}), similar to the values accounted for by the direct effect of the offspring's genotype, OOR~*j*~.

Chromosome 7 *P*-value profiles for GFP, RFP, FFP, and TFP were very similar, whereas MFP showed slight discrepancies (Fig. [2](#Fig2){ref-type="fig"}). Although two maternal QTL were initially detected for MFP, only the one in marker *D7Mit90* could be accepted after joint analysis (*P* = 7.48 × 10^−5^). The remaining traits showed two significant maternal QTL each, even after the joint analysis of both QTL. Maximum significances for the joint analysis of both QTL were obtained between markers *D7Mit90* and *D7Mit62* (*P* = 1.36 × 10^−5^; OR 7.4) and between markers *D7Mit301* and *D7Mit373* (*P* = 3.81 × 10^−6^; OR 7.8). Nevertheless, all OR between 7.4 and 7.9 showed significant estimates, with the exception of OR 7.7 characterized by marker *D7Mit301*. All fat pad maternal QTL showed negative estimates, indicating that maternal B6.C-H1 alleles contributed to leaner offspring 4--4.5 months after birth. The maternal QTL accounted for a significant percentage of the phenotypic variance, between 2.5% (MFP and TFP) and 9.7% (GFP).

Discussion {#Sec11}
==========

Maternal QTL are scarce in the scientific literature (Jarvis et al. [@CR28]; Wolf et al. [@CR49]). While numerous gene-mapping studies have dissected the mouse genome for direct effects on phenotypic traits, maternal genetic effects have often been ignored or roughly accounted for in QTL models. Maternal genetic effects cannot be addressed in standard F~2~ designs because all F~1~ mothers are genetically identical and the maternal contribution is reduced to environmental genetic effects. The unique experimental design in this study examining the F~2~ progeny originating from overlapping subcongenics provides a very powerful tool to dissect maternal QTL. The indirect effect of a female's genotype on her offspring's phenotype (Mousseau and Fox [@CR36]) can account for much of the phenotypic variance (Hager et al. [@CR24]) and occasionally contribute significant variation in traits expressed later in life (Mousseau and Fox [@CR37]). Analyses of maternal QTL require appropriate experimental designs and statistical methods should take into account that the genetic background of each female could contribute three times to her offspring, first by the direct inheritance of DNA, second through the maternal in utero environment, and third by the maternal postpartum environment during nursing. Under some experimental designs (Hager et al. [@CR24]), maternal genetic effects and imprinting effects could be difficult to differentiate. Our study distinguishes direct genetic effects from the combined effects of both maternally provided in utero and postpartum environments. No recombinant F~2~ mice were included in the analysis in order to properly account for the direct genetic contribution of each individual through the effects of the subcongenic strain and the offspring genotype in the chromosomal overlapping region of interest. The two types of maternally provided environments could be distinguished only by using cross-fostering studies. Genomic imprinting cannot be addressed under the F~2~ experimental design because the F~1~ heterozygous females (and males) can give rise to both of the reciprocal heterozygotes (background/donor and donor/background, given as paternal/maternal), instead of the experimental designs involving homozygous dams (Bartolomei and Tilghman [@CR4]; Hayward et al. [@CR25]; Reik and Walter [@CR41]). The origin of each allele cannot be identified; therefore, maternal (and paternal) imprinting effects cannot be completely discarded in our study.

Our use of subcongenic strains allows for a novel approach to QTL analysis, first applied by Clee et al. ([@CR11]) for mapping direct QTL in congenic mice. QTL effects within each overlapping region between strains can be directly assessed as the difference between donor and background subcongenic strains at a given chromosomal location. In this study, the approach described by Clee et al. ([@CR11]) has been adapted for the identification of maternal QTL, after accounting for the remaining sources of variation.

We report the identification of several significant maternal QTL on mouse chromosomes 2 and 7, all of them related to growth and obesity traits at later ages. A hotspot was detected in mouse chromosome 2 between 104.5 and 114.8 Mb (OR 2.5--2.6). In this region, the donor alleles of the maternal QTL were responsible for both lighter (9WK, BW, and LW) and fatter (GFP, RFP, FFP, and TFP) offspring (Fig. [1](#Fig1){ref-type="fig"}, Table [4](#Tab4){ref-type="table"}). Additional maternal QTL influencing the weight of the spleen, kidneys, and testis were also reported in Fig. [1](#Fig1){ref-type="fig"}. On mouse chromosome 7, growth maternal QTL peaked between 98.7 and 103.2 Mb (OR 7.7--7.9), whereas obesity maternal QTL showed significant estimates between 87.5 and 103.2 Mb, with a nonsignificant gap on OR 7.7 (\~98.7 Mb). Note that the length and boundaries of this nonsignificant genomic region linked with marker *D7Mit301* cannot be properly established. This is due to the presence of unknown donor alleles to the left and right of *D7Mit301* in B6.C-A, B6.C-B, and B6.C-L subcongenic strains that can extend up to *D7Mit62* (left side) and *D7Mit373* (right side). Nevertheless, this does not invalidate the two significant maternal QTL at the left and right of *D7Mit301*. All the maternal effect QTL accounted for a substantial percentage of the phenotypic variance (1.9-11.7%), agreeing with values reported by Wolf et al. ([@CR49]). This result highlights the importance of the maternal genome to the offspring's phenotype at latter ages. Although this source of variation is often ignored in QTL analyses, our results suggest that maternal effect QTL could be a common and significant source of genetic variation affecting growth and obesity. Maternal QTL donor alleles caused lighter (BW; Table [4](#Tab4){ref-type="table"}) and leaner (GFP, RFP, FFP, and TFP) F~2~ mice (Table [4](#Tab4){ref-type="table"}).

Our model included the random environmental effect of each litter in order to account for all the remaining litter-specific nongenetic sources of variation (e.g., feeding, temperature). Within this context, only maternal effects with a genetic basis were addressed by the reported QTL. All phenotypic traits involved in significant maternal QTL on chromosome 2 were recorded in 2-month-old mice 6 weeks after weaning and without additional contacts with their mother after the weaning date. The phenotypic traits involved in significant maternal QTL on chromosome 7 were recorded in 4--4.5-month-old mice. Within this context, these delayed indirect maternal genetic contributions must be related to biological mechanisms initiated during fetal or postnatal life and preserved for enough time to substantially modulate the adult phenotype.

According to our survey of the literature, maternal QTL for post-weaning mouse growth are limited to a study by Hager et al. ([@CR24]), and maternal QTL for obesity traits in adult mice were first suggested by Jarvis et al. ([@CR28]). However, the analysis of maternal effects at later ages has been a field of intense research in animals and humans. This phenomenon is known as fetal programming (Drake and Walker [@CR17]), with the primary hypothesis being that a stimulus or insult acting during critical stages of growth and development may permanently alter tissue structure and function (Barker and Clarck [@CR3]). Gestation and early neonatal life must be considered as potential sources of indirect maternal genetic influences on offspring. During the gestational period, levels of maternal gene products involved in placenta development may influence gene expression in the fetus. In addition, there is a flow of glucose, hormones, and amino acids from mother to offspring that could affect fetus growth and development (Myatt [@CR39]). It has also been shown that during gestation, maternal methyl supplements affect epigenetic variation and DNA methylation of offspring (Cooney et al. [@CR12]). On the other hand, the early neonatal period plays a key role in the development of the immune system (Wheeler et al. [@CR48]) and formation of the hypothalamus-pituitary-adrenal axis. Maternal care and milk quality may influence the formation of both of these systems. In species that give birth to immature young (e.g., mice, rats, and rabbits), much neuroendocrine development occurs in the postnatal period (Kapoor et al. [@CR30]). However, in humans and nonhuman primates, these developmental stages occur in utero. During neuroendocrine development, hormones circulating in the mother's body can directly regulate the development and activity of the fetus's central nervous system (Simerly [@CR45], [@CR46]; Bouret and Simerly [@CR7]). In fact, the formation of the hypothalamus-pituitary-adrenal axis could be one of the most reliable ways to maternally modify growth and adult fat pads of the offspring, given the close relation of the neuroendocrine system to growth and fat metabolism (Björntorp [@CR5]; Müller et al. [@CR38]). Obviously, all these biological mechanisms present a complex scenario in which the reported maternal QTL could be due to multiple genes involved in very different physiologic pathways.

The analysis of maternal QTL on the basis of overlapping subcongenic strains examines each genomic region separately; thus, any one gene in the significant genomic region may have a causative mutation. Although our approach allowed us to fine-map maternal QTL to relatively small genomic regions of less than 5 Mb, we can only suggest some plausible candidate genes. Several genes are valid candidates in the hotspot of mouse chromosome 2 (104.5--114.8 Mb). The acyltransferase-like 3 (*Agpat7*) gene and the gamma-butyrobetaine dioxygenase (*Bbox1*) gene are involved in phospholipid and carnitine biosynthetic processes, respectively. Both biosynthetic pathways have important effects during fetal life and the suckling period (Oey et al. [@CR40]; Shennan and Peaker [@CR44]). The brain-derived neurotrophic factor isoform 1 (*Bdnf1*) gene influences morphology and function of the brain (Liu et al. [@CR33]). *Bdnf1* is also expressed in the mammary gland and potentially plays a role in fat deposition. In addition, secretogranin 5 (*Scg5*) is one of the most promising candidate genes for growth and fat pad weight maternal QTL in chromosome 2, given the previously reported overexpression in our population of subcongenic mice (Farber et al. [@CR20]). For the second maternal QTL region reported in chromosome 7 (OR 7.4--7.6), only one candidate gene can be reported. Prolyl carboxypeptidase (*Prcp*) is located at 100.0 Mb and is expressed in several tissues including hypothalamic neurons (García-Horsman et al. [@CR21]). It has several known substrates including kallikrein and angiotensin II. Thus, *Prcp* could be a potential candidate maternal effects gene.

Our findings provide further evidence of the potentially important role maternal genetic effects may play in the determination of growth and body weight phenotypes. It is generally accepted that direct genetic effects modulate obesity, but the evidence presented here shows that maternal genetic effects can play a key role in fat deposition in adult mice. This is an important starting point to study the genetic basis of fetal programming. In addition, our results support the generation and maintenance of subcongenic strains as an important research tool, given that they can be used to characterize and fine-map genomic regions contributing to phenotypic traits of interest and maternal effects, as described here. Although our experimental design did not allow for the identification of specific genetic mechanisms involved in the maternal QTL, the genomic regions of interest were fine-mapped to small sections of chromosomes 2 and 7 spanning less than 10 Mb. Further investigation using our set of subcongenic strains, as well as generation of additional subcongenic strains, will contribute to the characterization of mutations underlying the reported maternal QTL.

We appreciate the excellent efforts of Vince De Vera, Noreene Shibata, and Glenda Espinal in mouse husbandry and with phenotypic data collection. This research was supported by the National Research Initiative grant 2005-35205-15453 from the USDA Cooperative State Research, Education, and Extension Service and by NIH grants DK69978 and DK52581. The research contract of J. Casellas was partially financed by Spain's Ministerio de Ciencia e Innovación (programs Juan de la Cierva and José Castillejo).

**Open Access** This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
